The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

In Vitro Toxicology Testing-Global Market Insights and Sales Trends 2024

In Vitro Toxicology Testing-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1846092

No of Pages : 112

Synopsis
In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.
The global In Vitro Toxicology Testing market size is expected to reach US$ 10240 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of In Vitro Toxicology Testing in various end use industries. The expanding demands from the Pharmaceuticals & Biopharmaceuticals Industry, Cosmetics and Household Products Industry, Food Industry and Chemicals Industry, are propelling In Vitro Toxicology Testing market. Cell Culture Technology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the High-throughput Technology segment is estimated at % CAGR for the next seven-year period.
Europe is projected to account for the largest share of the global market. The demand for in vitro toxicology testing in Europe is driven by the increasing number of investments in research and innovation by the European Commission to develop alternative methods to animal testing. The European Union has been a leader in supporting research to advance the development and validation of in vitro toxicology testing protocols for regulatory purposes.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Vitro Toxicology Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Vitro Toxicology Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Vitro Toxicology Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Vitro Toxicology Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Vitro Toxicology Testing covered in this report include SGS, Covance, Bio-Rad Laboratories, Qiagen, GE Healthcare, Eurofins Scientific, Merck, Thermo Fisher and Charles River Laboratories International, etc.
The global In Vitro Toxicology Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SGS
Covance
Bio-Rad Laboratories
Qiagen
GE Healthcare
Eurofins Scientific
Merck
Thermo Fisher
Charles River Laboratories International
Catalent
Cyprotex
Promega
Gentronix Limited
Ascendance Biotechnology
MB Research Laboratories
Global In Vitro Toxicology Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Vitro Toxicology Testing market, Segment by Type:
Cell Culture Technology
High-throughput Technology
Cellular Imaging Technology
Toxicogenomics
Global In Vitro Toxicology Testing market, by Application
Pharmaceuticals & Biopharmaceuticals Industry
Cosmetics and Household Products Industry
Food Industry
Chemicals Industry
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Vitro Toxicology Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of In Vitro Toxicology Testing
1.1 In Vitro Toxicology Testing Market Overview
1.1.1 In Vitro Toxicology Testing Product Scope
1.1.2 In Vitro Toxicology Testing Market Status and Outlook
1.2 Global In Vitro Toxicology Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In Vitro Toxicology Testing Market Size by Region (2018-2029)
1.4 Global In Vitro Toxicology Testing Historic Market Size by Region (2018-2023)
1.5 Global In Vitro Toxicology Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In Vitro Toxicology Testing Market Size (2018-2029)
1.6.1 North America In Vitro Toxicology Testing Market Size (2018-2029)
1.6.2 Europe In Vitro Toxicology Testing Market Size (2018-2029)
1.6.3 Asia-Pacific In Vitro Toxicology Testing Market Size (2018-2029)
1.6.4 Latin America In Vitro Toxicology Testing Market Size (2018-2029)
1.6.5 Middle East & Africa In Vitro Toxicology Testing Market Size (2018-2029)
2 In Vitro Toxicology Testing Market by Type
2.1 Introduction
2.1.1 Cell Culture Technology
2.1.2 High-throughput Technology
2.1.3 Cellular Imaging Technology
2.1.4 Toxicogenomics
2.2 Global In Vitro Toxicology Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In Vitro Toxicology Testing Historic Market Size by Type (2018-2023)
2.2.2 Global In Vitro Toxicology Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In Vitro Toxicology Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In Vitro Toxicology Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In Vitro Toxicology Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In Vitro Toxicology Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In Vitro Toxicology Testing Revenue Breakdown by Type (2018-2029)
3 In Vitro Toxicology Testing Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceuticals & Biopharmaceuticals Industry
3.1.2 Cosmetics and Household Products Industry
3.1.3 Food Industry
3.1.4 Chemicals Industry
3.2 Global In Vitro Toxicology Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In Vitro Toxicology Testing Historic Market Size by Application (2018-2023)
3.2.2 Global In Vitro Toxicology Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In Vitro Toxicology Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In Vitro Toxicology Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In Vitro Toxicology Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In Vitro Toxicology Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In Vitro Toxicology Testing Revenue Breakdown by Application (2018-2029)
4 In Vitro Toxicology Testing Competition Analysis by Players
4.1 Global In Vitro Toxicology Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In Vitro Toxicology Testing as of 2022)
4.3 Date of Key Players Enter into In Vitro Toxicology Testing Market
4.4 Global Top Players In Vitro Toxicology Testing Headquarters and Area Served
4.5 Key Players In Vitro Toxicology Testing Product Solution and Service
4.6 Competitive Status
4.6.1 In Vitro Toxicology Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 SGS
5.1.1 SGS Profile
5.1.2 SGS Main Business
5.1.3 SGS In Vitro Toxicology Testing Products, Services and Solutions
5.1.4 SGS In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.1.5 SGS Recent Developments
5.2 Covance
5.2.1 Covance Profile
5.2.2 Covance Main Business
5.2.3 Covance In Vitro Toxicology Testing Products, Services and Solutions
5.2.4 Covance In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Covance Recent Developments
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Profile
5.3.2 Bio-Rad Laboratories Main Business
5.3.3 Bio-Rad Laboratories In Vitro Toxicology Testing Products, Services and Solutions
5.3.4 Bio-Rad Laboratories In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Qiagen Recent Developments
5.4 Qiagen
5.4.1 Qiagen Profile
5.4.2 Qiagen Main Business
5.4.3 Qiagen In Vitro Toxicology Testing Products, Services and Solutions
5.4.4 Qiagen In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Qiagen Recent Developments
5.5 GE Healthcare
5.5.1 GE Healthcare Profile
5.5.2 GE Healthcare Main Business
5.5.3 GE Healthcare In Vitro Toxicology Testing Products, Services and Solutions
5.5.4 GE Healthcare In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.5.5 GE Healthcare Recent Developments
5.6 Eurofins Scientific
5.6.1 Eurofins Scientific Profile
5.6.2 Eurofins Scientific Main Business
5.6.3 Eurofins Scientific In Vitro Toxicology Testing Products, Services and Solutions
5.6.4 Eurofins Scientific In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Eurofins Scientific Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck In Vitro Toxicology Testing Products, Services and Solutions
5.7.4 Merck In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Thermo Fisher
5.8.1 Thermo Fisher Profile
5.8.2 Thermo Fisher Main Business
5.8.3 Thermo Fisher In Vitro Toxicology Testing Products, Services and Solutions
5.8.4 Thermo Fisher In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Thermo Fisher Recent Developments
5.9 Charles River Laboratories International
5.9.1 Charles River Laboratories International Profile
5.9.2 Charles River Laboratories International Main Business
5.9.3 Charles River Laboratories International In Vitro Toxicology Testing Products, Services and Solutions
5.9.4 Charles River Laboratories International In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Charles River Laboratories International Recent Developments
5.10 Catalent
5.10.1 Catalent Profile
5.10.2 Catalent Main Business
5.10.3 Catalent In Vitro Toxicology Testing Products, Services and Solutions
5.10.4 Catalent In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Catalent Recent Developments
5.11 Cyprotex
5.11.1 Cyprotex Profile
5.11.2 Cyprotex Main Business
5.11.3 Cyprotex In Vitro Toxicology Testing Products, Services and Solutions
5.11.4 Cyprotex In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Cyprotex Recent Developments
5.12 Promega
5.12.1 Promega Profile
5.12.2 Promega Main Business
5.12.3 Promega In Vitro Toxicology Testing Products, Services and Solutions
5.12.4 Promega In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Promega Recent Developments
5.13 Gentronix Limited
5.13.1 Gentronix Limited Profile
5.13.2 Gentronix Limited Main Business
5.13.3 Gentronix Limited In Vitro Toxicology Testing Products, Services and Solutions
5.13.4 Gentronix Limited In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Gentronix Limited Recent Developments
5.14 Ascendance Biotechnology
5.14.1 Ascendance Biotechnology Profile
5.14.2 Ascendance Biotechnology Main Business
5.14.3 Ascendance Biotechnology In Vitro Toxicology Testing Products, Services and Solutions
5.14.4 Ascendance Biotechnology In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Ascendance Biotechnology Recent Developments
5.15 MB Research Laboratories
5.15.1 MB Research Laboratories Profile
5.15.2 MB Research Laboratories Main Business
5.15.3 MB Research Laboratories In Vitro Toxicology Testing Products, Services and Solutions
5.15.4 MB Research Laboratories In Vitro Toxicology Testing Revenue (US$ Million) & (2018-2023)
5.15.5 MB Research Laboratories Recent Developments
6 North America
6.1 North America In Vitro Toxicology Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe In Vitro Toxicology Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Toxicology Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In Vitro Toxicology Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Toxicology Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In Vitro Toxicology Testing Market Dynamics
11.1 In Vitro Toxicology Testing Industry Trends
11.2 In Vitro Toxicology Testing Market Drivers
11.3 In Vitro Toxicology Testing Market Challenges
11.4 In Vitro Toxicology Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’